| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/978-3-030-36214-0_1 |
| P698 | PubMed publication ID | 32030672 |
| P50 | author | Roslyn Kemp | Q63373432 |
| P2093 | author name string | J K H Leman | |
| L Munoz-Erazo | |||
| P2860 | cites work | The role of neutrophils in cancer | Q64464492 |
| Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile. | Q64889220 | ||
| The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma | Q73434454 | ||
| Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma | Q74046178 | ||
| Significance of transforming growth factor beta1 as a new tumor marker for colorectal cancer | Q77523724 | ||
| MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases | Q83315903 | ||
| Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer | Q88679092 | ||
| Multiparametric analysis of colorectal cancer immune responses | Q90429149 | ||
| Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19 | Q90791080 | ||
| The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy | Q91028548 | ||
| Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma | Q91229374 | ||
| Compartmentalized gut lymph node drainage dictates adaptive immune responses | Q93112696 | ||
| Combination cancer immunotherapy targeting PD-1 and GITR can rescue CD8+ T cell dysfunction and maintain memory phenotype | Q58618143 | ||
| Association Between c-Myc and Colorectal Cancer Prognosis: A Meta-Analysis | Q59329181 | ||
| Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells | Q60302404 | ||
| Taxonomic profiling and populational patterns of bacterial bile salt hydrolase (BSH) genes based on worldwide human gut microbiome | Q61445030 | ||
| Preoperative Neutrophil-to-Lymphocyte Ratio (NLR) is Associated with Reduced Disease-free Survival Following Curative Resection of Pancreatic Adenocarcinoma | Q61812470 | ||
| Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series | Q63499786 | ||
| Cancer-associated fibroblasts enhance tumor-associated macrophages enrichment and suppress NK cells function in colorectal cancer | Q64069391 | ||
| TIAM1 promotes chemoresistance and tumor invasiveness in colorectal cancer | Q64074399 | ||
| Prognostic significance of elevated preoperative neutrophil-to-lymphocyte ratio for patients with colorectal cancer undergoing curative surgery: A meta-analysis | Q64235287 | ||
| The Role of Tumor-Associated Neutrophils in Colorectal Cancer | Q64273921 | ||
| Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts | Q22010913 | ||
| Comprehensive molecular characterization of human colon and rectal cancer | Q24630415 | ||
| Matrix crosslinking forces tumor progression by enhancing integrin signaling | Q24646370 | ||
| Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells | Q24648994 | ||
| Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation | Q24675931 | ||
| Tumor suppressor gene E-cadherin and its role in normal and malignant cells | Q24793413 | ||
| Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment | Q26745456 | ||
| Immune cell interplay in colorectal cancer prognosis | Q26781453 | ||
| Role of the normal gut microbiota | Q26798294 | ||
| Fusobacterium nucleatum: a commensal-turned pathogen | Q27014025 | ||
| Therapeutic value of EGFR inhibition in CRC and NSCLC: 15 years of clinical evidence | Q28071772 | ||
| Type, density, and location of immune cells within human colorectal tumors predict clinical outcome | Q28131662 | ||
| Diet rapidly and reproducibly alters the human gut microbiome | Q29547454 | ||
| Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells | Q29618126 | ||
| Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN | Q29619346 | ||
| Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation | Q29620116 | ||
| CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization | Q33553562 | ||
| Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack | Q34043164 | ||
| Macrophages, Neutrophils, and Cancer: A Double Edged Sword | Q56942176 | ||
| Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer | Q57254166 | ||
| Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers | Q58087983 | ||
| The biology of human natural killer-cell subsets | Q34430869 | ||
| The gut microbiota, bacterial metabolites and colorectal cancer | Q34437334 | ||
| Colorectal Carcinoma: Diagnostic, Prognostic, and Molecular Features | Q34532760 | ||
| The chromosomal instability pathway in colon cancer | Q34570062 | ||
| Small-bowel tumors: epidemiologic and clinical characteristics of 1260 cases from the connecticut tumor registry | Q34577924 | ||
| The epidemiology and pathogenesis of neoplasia in the small intestine | Q34601452 | ||
| Epidemiology of cancer of the small intestine | Q34628138 | ||
| Colorectal Cancer-Associated Fibroblasts are Genotypically Distinct | Q34729344 | ||
| Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin | Q34755571 | ||
| Microbiota organization is a distinct feature of proximal colorectal cancers | Q34793322 | ||
| Genetic pathways, prevention, and treatment of sporadic colorectal cancer | Q34832690 | ||
| NK cells and T cells cooperate during the clinical course of colorectal cancer | Q34933101 | ||
| Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer | Q35341867 | ||
| Challenges in the management of stage II colon cancer | Q35622839 | ||
| High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability | Q35787046 | ||
| Dietary antigens limit mucosal immunity by inducing regulatory T cells in the small intestine. | Q35907784 | ||
| Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer | Q35987354 | ||
| Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts | Q36232642 | ||
| Development and progression of colorectal neoplasia | Q36241935 | ||
| The consensus molecular subtypes of colorectal cancer | Q36258187 | ||
| Colonization with enterotoxigenic Bacteroides fragilis is associated with early-stage colorectal neoplasia | Q36267481 | ||
| The c-Myc target gene network | Q36564217 | ||
| Phenotyping of tumor-associated macrophages in colorectal cancer: Impact on single cell invasion (tumor budding) and clinicopathological outcome | Q36821128 | ||
| Gut macrophage phenotype is dependent on the tumor microenvironment in colorectal cancer | Q36865095 | ||
| TGF-beta 1 attenuates the acquisition and expression of effector function by tumor antigen-specific human memory CD8 T cells | Q36924688 | ||
| Effects of high-amylose maize starch and butyrylated high-amylose maize starch on azoxymethane-induced intestinal cancer in rats. | Q36959016 | ||
| High density of FOXP3-positive T cells infiltrating colorectal cancers with microsatellite instability | Q37010613 | ||
| Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin | Q37164254 | ||
| Tumor macrophages are pivotal constructors of tumor collagenous matrix. | Q37346644 | ||
| Metabolic Alterations Caused by KRAS Mutations in Colorectal Cancer Contribute to Cell Adaptation to Glutamine Depletion by Upregulation of Asparagine Synthetase | Q37352111 | ||
| Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction | Q37507447 | ||
| The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition | Q37587618 | ||
| Colorectal cancer cells suppress CD4+ T cells immunity through canonical Wnt signaling | Q37716516 | ||
| Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location | Q37992642 | ||
| Molecular mechanisms of treg-mediated T cell suppression | Q38008361 | ||
| Bile acids in the colon, from healthy to cytotoxic molecules. | Q38070345 | ||
| Natural cytotoxicity receptors and their ligands | Q38173692 | ||
| Cancer-Induced Alterations of NK-Mediated Target Recognition: Current and Investigational Pharmacological Strategies Aiming at Restoring NK-Mediated Anti-Tumor Activity | Q38203261 | ||
| The role of inflammation in colon cancer | Q38211073 | ||
| Cancer-associated fibroblasts connect metastasis-promoting communication in colorectal cancer | Q38411234 | ||
| Natural killer-like signature observed post therapy in locally advanced rectal cancer is a determinant of pathological response and improved survival. | Q38670280 | ||
| Advances in personalized cancer immunotherapy. | Q38783946 | ||
| MYC regulates the antitumor immune response through CD47 and PD-L1 | Q38787131 | ||
| Loss of SMAD4 Promotes Colorectal Cancer Progression by Accumulation of Myeloid-Derived Suppressor Cells through the CCL15-CCR1 Chemokine Axis | Q38837709 | ||
| Butyrate suppresses proliferation and migration of RKO colon cancer cells though regulating endocan expression by MAPK signaling pathway | Q39035026 | ||
| Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis | Q39119552 | ||
| Interaction with colon cancer cells hyperactivates TGF-β signaling in cancer-associated fibroblasts | Q39233221 | ||
| Wnt Signaling and Colorectal Cancer | Q39245323 | ||
| E-cadherin: A potential biomarker of colorectal cancer prognosis. | Q39355560 | ||
| Colorectal cancer cells activate adjacent fibroblasts resulting in FGF1/FGFR3 signaling and increased invasion | Q39585082 | ||
| Rac1 GTPase and the Rac1 exchange factor Tiam1 associate with Wnt-responsive promoters to enhance beta-catenin/TCF-dependent transcription in colorectal cancer cells | Q39934133 | ||
| Transforming growth factor beta1 promotes chromosomal instability in human papillomavirus 16 E6E7-infected cervical epithelial cells. | Q39945578 | ||
| Inclusion of BLIMP-1+ effector regulatory T cells improves the Immunoscore in a cohort of New Zealand colorectal cancer patients: a pilot study. | Q40367274 | ||
| Role of fibroblasts in HGF/SF-induced cohort migration of human colorectal carcinoma cells: fibroblasts stimulate migration associated with increased fibronectin production via upregulated TGF-beta1. | Q40942820 | ||
| Opposing effects of TGF-beta and IL-15 cytokines control the number of short-lived effector CD8+ T cells | Q41911200 | ||
| Butyrate downregulates alpha2beta1 integrin: a possible role in the induction of apoptosis in colorectal cancer cell lines | Q42288577 | ||
| Loss of SMAD4 Promotes Lung Metastasis of Colorectal Cancer by Accumulation of CCR1+ Tumor-Associated Neutrophils through CCL15-CCR1 Axis. | Q44029017 | ||
| Tumor-infiltrating FoxP3+ Tregs predict favorable outcome in colorectal cancer patients: A meta-analysis | Q46479553 | ||
| High levels of tumor-associated neutrophils are associated with improved overall survival in patients with stage II colorectal cancer. | Q47115909 | ||
| Hypermutation and microsatellite instability in gastrointestinal cancers | Q47655313 | ||
| The Rac GTPase in Cancer: From Old Concepts to New Paradigms | Q47953335 | ||
| Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins | Q48082495 | ||
| Interferon-γ and Colorectal Cancer: an up-to date | Q49199768 | ||
| Adoptive transfer of natural killer cells in combination with chemotherapy improves outcomes of patients with locally advanced colon carcinoma | Q50065725 | ||
| Mutations of key driver genes in colorectal cancer progression and metastasis | Q50097873 | ||
| The Prognostic Significance of the Tumor-infiltrating Programmed Cell Death-1+ to CD8+ Lymphocyte Ratio in Patients with Colorectal Cancer. | Q50873172 | ||
| The Role of Angiogenesis in Cancer Treatment. | Q50932310 | ||
| Alteration of the Antitumor Immune Response by Cancer-Associated Fibroblasts. | Q52353619 | ||
| High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. | Q53568149 | ||
| Activated human primary NK cells efficiently kill colorectal cancer cells in 3D spheroid cultures irrespectively of the level of PD-L1 expression. | Q53697011 | ||
| Immunohistochemical study of myofibroblasts in normal colonic mucosa, hyperplastic polyps, and adenomatous colorectal polyps. | Q54542890 | ||
| Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer. | Q55124199 | ||
| Close association between Fas ligand (FasL; CD95L)-positive tumor-associated macrophages and apoptotic cancer cells along invasive margin of colorectal carcinoma: a proposal on tumor-host interactions. | Q55312347 | ||
| Immunotherapy in colorectal cancer: for the select few or all? | Q55333223 | ||
| Expression of cancer-associated fibroblast markers in advanced colorectal cancer. | Q55340110 | ||
| International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study | Q56932170 | ||
| P304 | page(s) | 1-22 | |
| P577 | publication date | 2020-01-01 | |
| P1433 | published in | Advances in Experimental Medicine and Biology | Q4686385 |
| P1476 | title | The Intestinal Tumour Microenvironment | |
| P478 | volume | 1226 |
Search more.